Pharma Wholesale and Distribution Market Report 2021-2031
Forecasts by Type (Full-Line Wholesalers (FLWs), Short-Line Wholesalers (SLWs), Direct-to-Pharmacy (DTP), Hospitals, Clinics & Others, Mail Orders, Other), by Distributor Type (Ethical/Branded Pharma Products Distributors, Generic Pharma Products Distributors, Propaganda Cum Distribution (PCD) Franchise, OTC/Institutional Supply Pharma Distributors, Other), by Product Type (Prescription Drugs Wholesaling & Distribution, Antibiotics Wholesaling & Distribution, OTC Products Wholesaling & Distribution, Antiseptics Wholesaling & Distribution, Supplement Products Wholesaling & Distribution, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
The Pharma Wholesale and Distribution Market Report 2021-2031: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Distributors Invest Substantially In Support Of Infrastructure In The Supply Chain Just As Health Care Organizations Distributors are making significant investments to help tame the supply chain infrastructure, just as healthcare systems continue to invest in internal systems and processes to improve their ability to anticipate and respond to dynamic conditions. Forward-thinking distributors are ready to move with agility by improving system efficiencies, streamlining business processes, and employing and developing talented team members. Drug shortages are unavoidable, and even under the most vigilant surveillance, they will occur. When they do, some distributors already have a specialised team and system in place to locate backup inventory for short-term supply shortages, which they can use in conjunction with existing inventory management standards. In order to make timely, well-informed judgments based on product-specific knowledge, savvy distributors also maintain excellent supplier connections. These are just a few of the tactics that help to ensure a consistent supply at a reasonable price.
Increase In Maintenance And Cost Control Despite the fact that both generic and brand-name drugs are prone to shortages, generic products may be more sensitive to production problems. Generic medications are often produced on the same line as a variety of other items, and redundancy is not frequently built into their processes. When a common generic drug becomes unavailable, healthcare providers must consider if the most effective option is a more expensive name brand. They may also have to pay more for people to manage pharmacy automation systems and EMR adjustments that may be necessary when alternative prescriptions must be prescribed.
What Are These Questions You Should Ask Before Buying A Market Research Report? • How is the pharma wholesale and distribution market evolving? • What is driving and restraining the pharma wholesale and distribution market? • How will each pharma wholesale and distribution submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2031? • How will the market shares for each pharma wholesale and distribution submarket develop from 2021 to 2031? • What will be the main driver for the overall market from 2021 to 2031? • Will leading pharma wholesale and distribution markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the national markets change by 2031 and which geographical region will lead the market in 2031? • Who are the leading players and what are their prospects over the forecast period? • What are the pharma wholesale and distribution projects for these leading companies? • How will the industry evolve during the period between 2020 and 2031? • What are the implication of pharma wholesale and distribution projects taking place now and over the next 10 years? • Is there a greater need for product commercialisation to further scale the pharma wholesale and distribution market? • Where is the pharma wholesale and distribution market heading? And how can you ensure you are at the forefront of the market? • What can be the best investment options for new product and service lines? • What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the pharma wholesale and distribution market today, and over the next 10 years: • Our 457-page report provides 300 tables and 284 charts/graphs exclusively to you. • The report highlights key lucrative areas in the industry so you can target them – NOW. • Contains in-depth analyse of global, regional and national sales and growth • Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the pharma wholesale and distribution market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Delivers exclusive COVID-19 variations economic data specific to your market.
Forecasts to 2031 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharma wholesale and distribution prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Global Pharma Wholesale and Distribution Market (COVID Impact Analysis) by Type • Full-Line Wholesalers (FLWs) • Short-Line Wholesalers (SLWs) • Direct-to-Pharmacy (DTP) • Hospitals, Clinics & Others • Mail Orders • Other Types
Global Pharma Wholesale and Distribution Market (COVID Impact Analysis) by Distributor Type • Ethical/Branded Pharma Products Distributors • Generic Pharma Products Distributors • Propaganda Cum Distribution (PCD) Franchise • OTC/Institutional Supply Pharma Distributors • Other Distributor Types
Global Pharma Wholesale and Distribution Market (COVID Impact Analysis) by Product Type • Prescription Drugs Wholesaling & Distribution • OTC Products Wholesaling & Distribution • Antibiotics wholesaling & Distribution • Antiseptics Wholesaling & Distribution • Supplement Products Wholesaling & Distribution • Other Product Types
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:
• North America Pharma Wholesale and Distribution Market, 2021 to 2031 Market Outlook • U.S. Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Canada Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Mexico Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Europe Pharma Wholesale and Distribution Market, 2021 to 2031 Market Outlook • Germany Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Spain Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • United Kingdom Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • France Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Italy Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Rest of Europe Market Forecast & COVID Impact Analysis
• Asia Pacific Pharma Wholesale and Distribution Market, 2021 to 2031 Market Outlook • China Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Japan Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • India Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Australia Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • South Korea Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Rest of Asia Pacific Market Forecast & COVID Impact Analysis
• LAMEA Pharma Wholesale and Distribution Market, 2021 to 2031 Market Outlook • Brazil Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Turkey Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Saudi Arabia Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • South Africa Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • UAE Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis • Rest of Latin America, Middle East and Africa
The report also includes profiles and for some of the leading companies in the Pharma Wholesale and Distribution Market, 2021 to 2031, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth • Alfresa Holdings • AmerisourceBergen Corporation • Cardinal Health, Inc. • China Resources Pharmaceutical Group Limited • CR Pharmaceutical • CuraScript SD • Fortissa • Mutual Drug Company • Mawdsley-Brooks • Morris and Dickson • Medipal Holdings Corporation • McKesson Corporation • PHOENIX Group • Prodigy Health • Shanghai Fosun Pharmaceutical (Group) Co., Ltd • Sinopharm Group Co. Ltd • Smith Drug Company • Suzuken Co Ltd • Walgreens Boots Alliance, Inc.
Overall world revenue for Pharma Wholesale and Distribution Market, 2021 to 2031 in terms of value the market will surpass US$xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Pharma Wholesale and Distribution Market, 2021 to 2031 Market report helps you? In summary, our 450+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Pharma Wholesale and Distribution Market, 2021 to 2031 Market, with forecasts for Type, Distributor Type, Product Type each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 4 regional and 17 key national markets – See forecasts for the Pharma Wholesale and Distribution Market, 2021 to 2031 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 19 of the major companies involved in the Pharma Wholesale and Distribution Market, 2021 to 2031 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pharma Wholesale and Distribution Market, 2021 to 2031 Market and leading companies. You will find data, trends and predictions.
Buy our report today Pharma Wholesale and Distribution Market Report 2021-2031: Forecasts by Type (Full-Line Wholesalers (FLWs), Short-Line Wholesalers (SLWs), Direct-to-Pharmacy (DTP), Hospitals, Clinics & Others, Mail Orders, Other), by Distributor Type (Ethical/Branded Pharma Products Distributors, Generic Pharma Products Distributors, Propaganda Cum Distribution (PCD) Franchise, OTC/Institutional Supply Pharma Distributors, Other), by Product Type (Prescription Drugs Wholesaling & Distribution, Antibiotics Wholesaling & Distribution, OTC Products Wholesaling & Distribution, Antiseptics Wholesaling & Distribution, Supplement Products Wholesaling & Distribution, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview 1.1 Introduction to Pharma Wholesale and Distribution Market 1.2 Global Pharma Wholesale and Distribution Market Overview 1.3 What are the Objectives of this Report? 1.4 What is the Scope of the Report? 1.5 Pharma Wholesale and Distribution Market Definition 1.6 Why You Should Read This Report 1.7 What This Report Delivers 1.8 Key Questions Answered By This Analytical Report Include: 1.9 Who is This Report for? 1.10 Research Methodology 1.10.1 Primary Research 1.10.2 Secondary Research 1.10.3 Market Evaluation & Forecasting Methodology 1.11 Frequently Asked Questions (FAQs) 1.12 Associated Visiongain Reports 1.13 About Visiongain
2 Executive Summary
3 Pharma Wholesale and Distribution Industry Structure 3.1 Overview 3.2 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry 3.2.1 Full-Line Wholesalers (FLWs) 3.2.2 Short-Line Wholesalers (SLWs) 3.3 The Chain of Distribution: Wholesalers vs. Logistic Service Providers 3.3.1 Secondary Wholesalers 3.3.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent 3.3.3 Major Wholesalers: Distribution of a Large Number of Products to Generate High Profits 3.3.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain 3.3.5 Pharmacy Benefit Managers (PBMs): 3.4 Generative Revenue and Profit 3.4.1 Forward Buying to Avoid Price Increases 3.4.2 Fee-for-Service: A Clear Pricing Structure 3.4.3 Discounts: Incentives for Prompt Payment or Bulk Purchases 3.4.4 Clawback: The Recovery of Reimbursement Costs by Governments 3.4.5 Parallel Trade: Different Attitudes in Europe and the US 3.5 COVID-19 And Restrictions Of Supply: Adaptation To New Problems 3.6 How The Wholesaler Makes Money From Distribution Of Drugs? 3.7 Digital Supply Chain 3.8 Wholesaling And Distribution In Low- And Middle-Income Countries 3.8.1 Creating A Healthier Wholesaler/Distributor Market 3.9 Value Added Services 3.9.1 Independent Pharmacy Services 3.9.2 Generic Sourcing Programs 3.9.3 Hub Services 3.10 Distribution 3.10.1 Costs Incurred By Distributors Pharmaceutical Distribution 3.10.2 Ordering Can Be Done Over The Phone Or Electronically 3.10.3 Value Added By Distributors 3.10.4 Wholesalers Offers Wide Range Of Commercial Services 3.11 Pharmaceutical Distribution Ecosystem 3.11.1 Direct Role In Ensuring That Patients Have Access To Pharmaceuticals 3.11.2 Payor 3.11.3 Ecosystem Support Access To Pharmaceuticals 3.11.4 Hidden Negotiators Help Patients Get Access To Pharmaceuticals 3.12 Market Structure Of Pharmaceutical Wholesaling And Retailing In The Europe 3.13 Market Structure in Wholesaling 3.14 Integration in Distribution 3.14.1 Horizontal Integration 3.14.2 Vertical Integration
4 Global Market Dynamics 4.1 Market Driving Factors 4.1.1 Distributors Invest Substantially In Support Of Infrastructure In The Supply Chain Just As Health Care Organisations 4.1.2 Increase In Maintenance And Cost Control 4.1.3 Connected Trends That Lay Great Importance On Individual Treatment Are The Consequence Of Personalized Care 4.2 Market Restraining Factors 4.2.1 To Be An Authorised Trading Partner, Distributors Must Be Licenced. 4.2.2 The Market Is More Affected By Disruptions To The Supply Chain Involving A Single Or Double Source Than By Numerous Sources 4.3 Opportunities in the Global Market 4.3.1 Growth Because Of Increasing Subsidised Spending Through Programmes 4.3.2 Complexity Decreasing: From Raw Data To Operating Analytics 4.3.3 Taking Advantage Of Outside Consultancy Services 4.4 Challenges in the Global Market 4.4.1 The Issues Of Day-To-Day Procedures And Cultural Standards 4.4.2 Pharmaceutical Supply Chain Is Complicated 4.5 SWOT Analysis 4.6 PEST Analysis 4.6.1 Political 4.6.2 Economical 4.6.3 Social 4.6.4 Technology 4.7 Porters Analysis 4.7.1 Competitive Rivalry 4.7.2 Bargaining Power Of Suppliers 4.7.3 Bargaining Power Of Customers 4.7.4 Threat Of New Entrants 4.7.5 Threat Of Substitutes
5 Global Pharma Wholesale and Distribution Market Analysis 5.1 Global Market Outlook 5.1.1 The World Pharmaceutical Wholesale and Distribution Market, Restricted by Government Price Reductions and Generic Substitution 5.2 Global Market Size Estimation and Forecast 5.2.1 Pre-COVID-19 Market Scenario 5.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 5.3 Regional Market Size Estimation and Forecast 5.3.1 Pre-COVID-19 Market Scenario 5.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Market Size Estimation and Forecast by Type 6.1 Segment Overview 6.1.1 Full-Line Wholesalers (FLWs) 6.1.2 Short-Line Wholesalers (SLWs) 6.1.3 Direct-to-Pharmacy (DTP) 6.1.4 Hospitals, Clinics & Others 6.1.5 Mail Orders 6.1.6 Other Types 6.2 Pre-COVID-19 Market Scenario 6.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Market Size Estimation and Forecast by by Distributor Type 7.1 Segment Overview 7.1.1 Ethical/Branded Pharma Products Distributors 7.1.2 Generic Pharma Products Distributors 7.1.3 Propaganda Cum Distribution (PCD) Franchise 7.1.4 OTC/Institutional Supply Pharma Distributors 7.1.5 Other Distributor Type 7.2 Pre-COVID-19 Market Scenario 7.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Market Size Estimation and Forecast by Product Type 8.1 Segment Overview 8.1.1 Prescription Drugs Wholesaling & Distribution 8.1.2 OTC Products Wholesaling & Distribution 8.1.3 Antibiotics Wholesaling & Distribution 8.1.4 Antiseptics Wholesaling & Distribution 8.1.5 Supplement Products Wholesaling & Distribution 8.1.6 Other Product Type 8.2 Pre-COVID-19 Market Scenario 8.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 North America Pharma Wholesale and Distribution Market Analysis 9.1 North America Market Outlook 9.2 North America Market Size Estimation and Forecast 9.2.1 Pre-COVID-19 Market Scenario 9.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 9.3 Country Market Size Estimation and Forecast 9.3.1 Pre-COVID-19 Market Scenario 9.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 9.4 North America Market Size Estimation and Forecast by Type 9.4.1 Pre-COVID-19 Market Scenario 9.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 9.5 North America Market Size Estimation and Forecast by by Distributor Type 9.5.1 Pre-COVID-19 Market Scenario 9.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 9.6 North America Market Size Estimation and Forecast by Product Type 9.6.1 Pre-COVID-19 Market Scenario 9.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 9.7 US Pharma Wholesale and Distribution Market Analysis 9.7.1 The Leading National Markets: the US Dominates in 2020 9.7.2 The US Pharma Wholesale and Distribution Market 9.7.3 Legislation to Prevent Counterfeit Drugs Can Differ Between States 9.7.4 Pre-COVID-19 Market Scenario 9.7.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 9.8 Canada Pharma Wholesale and Distribution Market Analysis 9.8.1 Development of Wholesaling and Distribution in Canada 9.8.2 Pre-COVID-19 Market Scenario 9.8.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 9.9 Mexico Pharma Wholesale and Distribution Market Analysis 9.9.1 Pre-COVID-19 Market Scenario 9.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Europe Pharma Wholesale and Distribution Market Analysis 10.1 The Leading European (EU5) Pharma Wholesale and Distribution Markets 10.1.1 The Difference Between the US and European Markets 10.2 Europe Market Size Estimation and Forecast 10.2.1 Pre-COVID-19 Market Scenario 10.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.3 Country Market Size Estimation and Forecast 10.3.1 Pre-COVID-19 Market Scenario 10.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.4 Europe Market Size Estimation and Forecast by Type 10.4.1 Pre-COVID-19 Market Scenario 10.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.5 Europe Market Size Estimation and Forecast by by Distributor Type 10.5.1 Pre-COVID-19 Market Scenario 10.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.6 Europe Market Size Estimation and Forecast by Product Type 10.6.1 Pre-COVID-19 Market Scenario 10.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.7 Germany Pharma Wholesale and Distribution Market Analysis 10.7.1 Healthcare Reform In Germany 10.7.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law 10.7.3 Pre-COVID-19 Market Scenario 10.7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.8 UK Pharma Wholesale and Distribution Market Analysis 10.8.1 Development Extensive Networks In The United Kingdom 10.8.2 Price Cuts in the UK 10.8.3 Pre-COVID-19 Market Scenario 10.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.9 France Pharma Wholesale and Distribution Market Analysis 10.9.1 The Laws Implemented In France For The Wholesale Distribution Of Pharmaceuticals And Therapeutic Items 10.9.2 Pre-COVID-19 Market Scenario 10.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.10 Italy Pharma Wholesale and Distribution Market Analysis 10.10.1 The Significant Development In Italian Pharmaceutical Sector In Recent Years 10.10.2 Pre-COVID-19 Market Scenario 10.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.11 Spain Pharma Wholesale and Distribution Market Analysis 10.11.1 Full Line Wholesalers Are The Key Actors In The Spanish Pharmaceutical Distribution Industry 10.11.2 Pre-COVID-19 Market Scenario 10.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 10.12 Rest of Europe Pharma Wholesale and Distribution Market Analysis 10.12.1 Pre-COVID-19 Market Scenario 10.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Asia-Pacific Pharma Wholesale and Distribution Market Analysis 11.1 Asia-Pacific Market Outlook 11.2 Asia-Pacific Market Size Estimation and Forecast 11.2.1 Pre-COVID-19 Market Scenario 11.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.3 Country Market Size Estimation and Forecast 11.3.1 Pre-COVID-19 Market Scenario 11.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.4 Asia-Pacific Market Size Estimation and Forecast by Type 11.4.1 Pre-COVID-19 Market Scenario 11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.5 Asia-Pacific Market Size Estimation and Forecast by by Distributor Type 11.5.1 Pre-COVID-19 Market Scenario 11.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.6 Asia-Pacific Market Size Estimation and Forecast by Product Type 11.6.1 Pre-COVID-19 Market Scenario 11.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.7 China Pharma Wholesale and Distribution Market Analysis 11.7.1 Regulatory Aspects In China 11.7.2 Pre-COVID-19 Market Scenario 11.7.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.8 India Pharma Wholesale and Distribution Market Analysis 11.8.1 Various Strategies & Intitative Taken In India For Pharmaceutical Businesses 11.8.2 Pre-COVID-19 Market Scenario 11.8.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.9 Japan Pharma Wholesale and Distribution Market Analysis 11.9.1 Strategies Adopted in Japan For Entering In Pharma Wholesale & Distribution 11.9.2 Pre-COVID-19 Market Scenario 11.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.10 South Korea Pharma Wholesale and Distribution Market Analysis 11.10.1 In South Korea The Focus On Their Primary Strengths Of R&D And Marketing 11.10.2 Pre-COVID-19 Market Scenario 11.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.11 Australia Pharma Wholesale and Distribution Market Analysis 11.11.1 Increased Demand Across Australia For Many Of The Thousand Pharmacies In 2020 11.11.2 Pre-COVID-19 Market Scenario 11.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 11.12 Rest of Asia-Pacific Pharma Wholesale and Distribution Market Analysis 11.12.1 Pre-COVID-19 Market Scenario 11.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 LAMEA Pharma Wholesale and Distribution Market Analysis 12.1 LAMEA Market Outlook 12.2 LAMEA Market Size Estimation and Forecast 12.2.1 Pre-COVID-19 Market Scenario 12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.3 Country Market Size Estimation and Forecast 12.3.1 Pre-COVID-19 Market Scenario 12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.4 LAMEA Market Size Estimation and Forecast by Type 12.4.1 Pre-COVID-19 Market Scenario 12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.5 LAMEA Market Size Estimation and Forecast by by Distributor Type 12.5.1 Pre-COVID-19 Market Scenario 12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.6 LAMEA Market Size Estimation and Forecast by Product Type 12.6.1 Pre-COVID-19 Market Scenario 12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.7 Brazil Pharma Wholesale and Distribution Market Analysis 12.7.1 Brazil: Pharma and Wholesale Distribution Market 12.7.2 Pre-COVID-19 Market Scenario 12.7.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.8 South Africa Pharma Wholesale and Distribution Market Analysis 12.8.1 Pre-COVID-19 Market Scenario 12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.9 Saudi Arabia Pharma Wholesale and Distribution Market Analysis 12.9.1 Distribution and Wholesale Regulations in Saudi Arabia 12.9.2 Pre-COVID-19 Market Scenario 12.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.10 Turkey Pharma Wholesale and Distribution Market Analysis 12.10.1 Distribution and Wholesale Regulations in Turkey 12.10.2 Pre-COVID-19 Market Scenario 12.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.11 UAE Pharma Wholesale and Distribution Market Analysis 12.11.1 Distribution and Wholesale Regulations in UAE 12.11.2 Pre-COVID-19 Market Scenario 12.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.12 Rest of LAMEA Pharma Wholesale and Distribution Market Analysis 12.12.1 Pre-COVID-19 Market Scenario 12.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Leading Company Profiles 13.1 Morris and Dickson 13.1.1 Company Snapshot 13.1.2 Company Overview 13.1.3 Company Product Benchmarking 13.2 Alfresa Holdings 13.2.1 Company Snapshot 13.2.2 Company Overview 13.2.3 Company Financial Profile (2017-2021) 13.2.4 Company Product Benchmarking 13.2.5 Company Recent Developments 13.3 Walgreens Boots Alliance, Inc 13.3.1 Company Snapshot 13.3.2 Company Overview 13.3.3 Company Financial Profile (2016-2020) 13.3.4 Company Product Benchmarking 13.3.5 Company Recent Developments 13.4 AmerisourceBergen Corporation 13.4.1 Company Snapshot 13.4.2 Company Overview 13.4.3 Company Financial Profile (2016-2020) 13.4.4 Company Product Benchmarking 13.4.5 Company Recent Developments 13.5 Sinopharm Group Co. Ltd 13.5.1 Company Snapshot 13.5.2 Company Overview 13.5.3 Company Financial Profile (2016-2020) 13.5.4 Company Product Benchmarking 13.5.5 Company Recent Developments 13.6 Suzuken Co Ltd 13.6.1 Company Snapshot 13.6.2 Company Overview 13.6.3 Company Financial Profile (2017-2021) 13.6.4 Company Product Benchmarking 13.6.5 Company Recent Developments 13.7 Shanghai Fosun Pharmaceutical (Group) Co., Ltd 13.7.1 Company Snapshot 13.7.2 Company Overview 13.7.3 Company Financial Profile (2016-2020) 13.7.4 Company Product Benchmarking 13.7.5 Company Recent Developments 13.8 China Resources Pharmaceutical Group Limited 13.8.1 Company Snapshot 13.8.2 Company Overview 13.8.3 Company Financial Profile (2016-2020) 13.8.4 Company Product Benchmarking 13.8.5 Company Recent Developments 13.9 Smith Drug Company 13.9.1 Company Snapshot 13.9.2 Company Overview 13.9.3 Company Product Benchmarking 13.10 CuraScript SD 13.10.1 Company Snapshot 13.10.2 Company Overview 13.10.3 Company Product Benchmarking 13.11 Cardinal Health, Inc. 13.11.1 Company Snapshot 13.11.2 Company Overview 13.11.3 Company Financial Profile (2016-2020) 13.11.4 Company Product Benchmarking 13.11.5 Company Recent Developments 13.12 Mutual Drug Company 13.12.1 Company Snapshot 13.12.2 Company Overview 13.12.3 Company Product Benchmarking 13.13 CR Pharmaceutical 13.13.1 Company Snapshot 13.13.2 Company Overview 13.13.3 Company Financial Profile (2016-2020) 13.13.4 Company Product Benchmarking 13.13.5 Company Recent Developments 13.14 McKesson Corporation 13.14.1 Company Snapshot 13.14.2 Company Overview 13.14.3 Company Financial Profile (2017-2021) 13.14.4 Company Product Benchmarking 13.14.5 Company Recent Developments 13.15 Medipal Holdings Corporation 13.15.1 Company Snapshot 13.15.2 Company Overview 13.15.3 Company Financial Profile (2017-2021) 13.15.4 Company Product Benchmarking 13.15.5 Company Recent Developments 13.16 PHOENIX Group 13.16.1 Company Snapshot 13.16.2 Company Overview 13.16.3 Company Financial Profile 13.16.4 Company Product Benchmarking 13.16.5 Company Recent Developments 13.17 Mawdsley-Brooks 13.17.1 Company Snapshot 13.17.2 Company Overview 13.17.3 Company Product Benchmarking 13.18 Prodigy Health 13.18.1 Company Snapshot 13.18.2 Company Overview 13.18.3 Company Product Benchmarking 13.19 Fortissa 13.19.1 Company Snapshot 13.19.2 Company Overview 13.19.3 Company Product Benchmarking
14 Conclusion and Recommendations 14.1 Conclusion Summary 14.2 Recommendations 14.2.1 Reduction In The Layers Of Distribution 14.2.2 More Market-Friendly Regulations 14.2.3 Technological Innovation
15 Glossary Terms
List of Tables Table 1. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 2. Global Pharma Wholesale and Distribution Market Snapshot, 2021 & 2031 (US$million, CAGR %) Table 3. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 4. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 5. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 6. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 7. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 8. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 9. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 10. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 11. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 12. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 13. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 14. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 15. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 16. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 17. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 18. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 19. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 20. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 21. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 22. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 23. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 24. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 25. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 26. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 27. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 28. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 29. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 30. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 31. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 32. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 33. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 34. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 35. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 36. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 37. orth America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 38. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 39. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 40. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 41. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 42. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 43. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 44. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 45. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 46. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 47. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 48. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 49. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 50. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 51. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 52. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 53. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 54. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 55. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 56. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 57. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 58. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 59. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 60. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 61. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 62. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 63. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 64. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 65. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 66. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 67. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 68. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 69. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 70. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 71. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 72. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 73. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 74. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 75. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 76. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 77. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 78. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 79. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 80. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 81. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 82. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 83. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 84. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 85. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 86. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 87. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 88. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 89. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 90. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 91. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 92. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 93. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 94. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 95. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 96. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 97. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 98. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 99. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 100. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 101. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 102. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 103. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 104. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 105. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 106. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 107. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 108. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 109. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 110. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 111. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 112. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 113. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 114. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 115. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 116. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 117. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 118. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 119. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 120. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 121. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 122. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 123. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 124. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 125. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 126. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 127. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 128. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 129. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 130. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 131. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 132. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 133. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 134. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 135. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 136. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 137. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 138. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 139. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 140. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 141. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 142. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 143. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 144. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 145. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 146. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 147. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 148. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 149. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 150. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 151. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 152. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 153. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 154. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 155. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 156. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 157. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 158. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 159. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 160. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 161. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 162. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 163. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 164. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 165. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 166. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 167. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 168. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 169. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 170. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 171. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 172. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 173. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 174. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 175. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 176. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 177. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 178. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%)) Table 179. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery) Table 180. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery) Table 181. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery) Table 182. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery) Table 183. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 184. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 185. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 186. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 187. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 188. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 189. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 190. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 191. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 192. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 193. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 194. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 195. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 196. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 197. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 198. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 199. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 200. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 201. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 202. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 203. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 204. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 205. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 206. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 207. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 208. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%)) Table 209. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery) Table 210. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery) Table 211. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery) Table 212. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery) Table 213. Morris and Dickson.: Company Information Table 214. Morris and Dickson.: Company Service Benchmarking Table 215. Alfresa Holdings.: Company Information Table 216. Alfresa Holdings.: Company Revenue 2017-2021 (US$ Mn, AGR %) Table 217. Alfresa Holdings.: Company Service Benchmarking Table 218. Alfresa Holdings.: Company Recent Developments till Apr,2021 Table 219. Walgreens Boots Alliance, Inc: Company Information Table 220. Walgreens Boots Alliance, Inc: Company Revenue 2016-2020 (US$ Mn, AGR %) Table 221. Walgreens Boots Alliance, Inc: Company Product and Service Benchmarking Table 222. Walgreens Boots Alliance, Inc: Company Recent Developments till May,2021 Table 223. AmerisourceBergen Corporation.: Company Information Table 224. AmerisourceBergen Corporation.: Company Revenue 2016-2020(US$ Mn, AGR %) Table 225. AmerisourceBergen Corporation.: Company Product and Service Table 226. AmerisourceBergen Corporation Company Recent Developments till Feb,2021 Table 227. Sinopharm Group Co. Ltd: Company Information Table 228. Sinopharm Group Co. Ltd: Company Revenue 2016-2020(US$ Mn, AGR %) Table 229. Sinopharm Group Co. Ltd: Company Product and Service Table 230. Sinopharm Group Co. Ltd.: Company Recent Developments till Feb,2021 Table 231. Suzuken Co Ltd : Company Information Table 232. Suzuken Co Ltd: Company Revenue 2017-2021 (US$ Mn, AGR %) Table 233. Suzuken Co Ltd : Company Product and Service Benchmarking Table 234. Suzuken Co Ltd: Company Recent Developments till Aug,2021 Table 235. Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company Information Table 236. Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company Revenue 2016-2020(US$ Mn, AGR %) Table 237. Suzuken Co Ltd : Company Product and Service Benchmarking Table 238. Shanghai Fosun Pharmaceutical (Group) Co., Ltd .: Company Recent Developments till Feb,2021 Table 239. China Resources Pharmaceutical Group Limited.: Company Information Table 240. China Resources Pharmaceutical Group Limited.: Company Revenue 2016-2020 (US$ Mn, AGR %) Table 241. China Resources Pharmaceutical Group Limited.: Company Service Benchmarking Table 242. China Resources Pharmaceutical Group Limited.: Company Recent Developments till Apr,2021 Table 243. Smith Drug Company: Company Information Table 244. Smith Drug Company : Company Product and Service Benchmarking Table 245. CuraScript SD.: Company Information Table 246. CuraScript SD.: Company Product and Service Benchmarking Table 247. Cardinal Health, Inc.: Company Information Table 248. Cardinal Health, Inc : Company Revenue 2016-2020 (US$ Mn, AGR %) Table 249. Cardinal Health, Inc.: Company Product and Service Benchmarking Table 250. Cardinal Health, Inc.. Recent Developments till Apr,2021 Table 251. Mutual drug Company: Company Information Table 252. Mutual drug Company: Company Product and Service Benchmarking Table 253. CR Pharmaceutical.: Company Information Table 254. CR Pharmaceutical.: Company Revenue 2016-2020 (US$ Mn, AGR %) Table 255. CR Pharmaceutical.: Company Product and Service Benchmarking Table 256. CR Pharmaceutical.: Company Recent Developments till Feb,2021 Table 257. McKesson Corporation.: Company Information Table 258. McKesson Corporation: Revenue 2017-2021 (US$ Mn, AGR %) Table 259. McKesson Corporation: Product and Service Table 260. McKesson Corporation: Recent Developments till Apr,2021 Table 261. Medipal Holdings Corporation: Company Information Table 262. Medipal Holdings Corporation: Revenue 2017-2021 (US$ Mn, AGR %) Table 263. Medipal Holdings Corporation: Company Product and Service Table 264. Medipal Holdings Corporation.: Company Recent Developments till Feb,2021
List of Figures Figure 1. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%)) Figure 2. Global Pharma Wholesale and Distribution Market Segmentation Figure 3. Full Line Wholesaler Figure 4. Pharmaceutical Supply Chain Figure 5. Consolidation Of Pharmaceutical Distributors And Retail Pharmacy Chains Figure 6. Wholesaling And Distribution In Low- And Middle-Income Countries Figure 7. Pharmaceutical Distribution Ecosystem Figure 8. SWOT Analysis Figure 9. PEST Analysis Figure 10. Porters Five Forces Figure 11. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%)) Figure 12. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 13. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 14. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 15. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 16. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%)) Figure 17. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 18. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 19. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 20. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 21. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%)) Figure 22. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 23. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 24. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 25. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 26. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%)) Figure 27. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 28. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 29. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 30. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 31. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%)) Figure 32. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 33. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 34. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 35. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 36. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%)) Figure 37. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 38. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 39. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 40. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 41. North America Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%)) Figure 42. North America Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 43. North America Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 44. North America Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 45. North America Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 46. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%)) Figure 47. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 48. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 49. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 50. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 51. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%)) Figure 52. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 53. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 54. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 55. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 56. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%)) Figure 57. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 58. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 59. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 60. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 61. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 62. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 63. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 64. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 65. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 66. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 67. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 68. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 69. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 70. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 71. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 72. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 73. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 74. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 75. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 76. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%)) Figure 77. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 78. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 79. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 80. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 81. Europe Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%)) Figure 82. Europe Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 83. Europe Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 84. Europe Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 85. Europe Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 86. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%)) Figure 87. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 88. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 89. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 90. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 91. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%)) Figure 92. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 93. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 94. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 95. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 96. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%)) Figure 97. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 98. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 99. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 100. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 101. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 102. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 103. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 104. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 105. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 106. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 107. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 108. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 109. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 110. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 111. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 112. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 113. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 114. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 115. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 116. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 117. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 118. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 119. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 120. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 121. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 122. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 123. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 124. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 125. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 126. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 127. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 128. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 129. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 130. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 131. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%)) Figure 132. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 133. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 134. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 135. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 136. Asia-Pacific Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%),) Figure 137. Asia-Pacific Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%),)(V-Shape Recovery) Figure 138. Asia-Pacific Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%),)(W-Shape Recovery) Figure 139. Asia-Pacific Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%),)(U-Shape Recovery) Figure 140. Asia-Pacific Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%),)(L-Shape Recovery) Figure 141. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%)) Figure 142. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 143. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 144. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 145. Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 146. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%)) Figure 147. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 148. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 149. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 150. Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 151. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%)) Figure 152. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 153. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 154. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 155. Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 156. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 157. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 158. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 159. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 160. China Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 161. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 162. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 163. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 164. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 165. India Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 166. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 167. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 168. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 169. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 170. Japan Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 171. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 172. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 173. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 174. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 175. South Korea Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 176. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 177. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 178. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 179. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 180. Australia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 181. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 182. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 183. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 184. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 185. Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 186. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%)) Figure 187. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 188. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 189. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 190. LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 191. LAMEA Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%)) Figure 192. LAMEA Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 193. LAMEA Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 194. LAMEA Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 195. LAMEA Pharma Wholesale and Distribution Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 196. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%)) Figure 197. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 198. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 199. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 200. LAMEA Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 201. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%)) Figure 202. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 203. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 204. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 205. LAMEA Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 206. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%)) Figure 207. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(V-Shape Recovery) Figure 208. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(W-Shape Recovery) Figure 209. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(U-Shape Recovery) Figure 210. LAMEA Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%))(L-Shape Recovery) Figure 211. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 212. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 213. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 214. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 215. Brazil Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 216. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 217. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 218. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 219. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 220. South Africa Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 221. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 222. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 223. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 224. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 225. Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 226. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 227. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 228. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 229. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 230. Turkey Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 231. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 232. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 233. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 234. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 235. UAE Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 236. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 237. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery) Figure 238. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery) Figure 239. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery) Figure 240. Rest of LAMEA Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) Figure 241. Alfresa Holdings.: Company Revenue 2017-2021 (US$ Mn, AGR %) Figure 242. Alfresa Holdings.: Company Operating Income 2017-2021 (US$ Mn, AGR %) Figure 243. Alfresa Holdings.: Company Net Income 2017-2021 (US$ Mn, AGR %) Figure 244. Alfresa Holdings: Company EBITDA 2017-2021 (US$ Mn, AGR %) Figure 245. Walgreens Boots Alliance, Inc: Company Revenue 2016-2020 (US$ Mn, AGR %) Figure 246. Walgreens Boots Alliance, Inc: Company Operating Income 2016-2020 (US$ Mn, AGR %) Figure 247. Walgreens Boots Alliance, Inc: Company Net Income 2016-2020 (US$ Mn, AGR %) Figure 248. Walgreens Boots Alliance, Inc: Company EBITDA 2016-2020 (US$ Mn, AGR %) Figure 249. AmerisourceBergen Corporation.: Company Revenue 2016-2020(US$ Mn, AGR %) Figure 250. AmerisourceBergen Corporation.: Company Operating Income 2016-2020(US$ Mn, AGR %) Figure 251. AmerisourceBergen Corporation.: Company Net Income 2016-2020(US$ Mn, AGR %) Figure 252. AmerisourceBergen Corporation.: Company EBITDA 2016-2020(US$ Mn, AGR %) Figure 253. Sinopharm Group Co. Ltd: Company Revenue 2016-2020(US$ Mn, AGR %) Figure 254. Sinopharm Group Co. Ltd: Company Operating Income 2016-2020(US$ Mn, AGR %) Figure 255. Sinopharm Group Co. Ltd: Company Net Income 2016-2020(US$ Mn, AGR %) Figure 256. Sinopharm Group Co. Ltd: Company EBITDA 2016-2020(US$ Mn, AGR %) Figure 257. Suzuken Co Ltd: Company Revenue 2017-2021 (US$ Mn, AGR %) Figure 258. Suzuken Co Ltd: Company Operating Income 2017-2021 (US$ Mn, AGR %) Figure 259. MediCaps Limited. : Company Net Income 2017-2021 (US$ Mn, AGR %) Figure 260. Suzuken Co Ltd: Company EBITDA 2017-2021 (US$ Mn, AGR %) Figure 261. Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company Revenue 2016-2020(US$ Mn, AGR %) Figure 262. Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company Operating Income 2016-2020(US$ Mn, AGR %) Figure 263. Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company Net Income 2016-2020(US$ Mn, AGR %) Figure 264. Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company EBITDA 2016-2020(US$ Mn, AGR %) Figure 265. China Resources Pharmaceutical Group Limited.: Company Revenue 2016-2020 (US$ Mn, AGR %) Figure 266. China Resources Pharmaceutical Group Limited.: Company Operating Income 2016-2020 (US$ Mn, AGR %) Figure 267. China Resources Pharmaceutical Group Limited.: Company Net Income 2016-2020 (US$ Mn, AGR %) Figure 268. China Resources Pharmaceutical Group Limited: Company EBITDA 2016-2020 (US$ Mn, AGR %) Figure 269. Cardinal Health, Inc.. : Company Revenue 2016-2020 (US$ Mn, AGR %) Figure 270. Cardinal Health, Inc: Company Operating Income 2016-2020 (US$ Mn, AGR %) Figure 271. Cardinal Health, Inc. : Company Net Income 2016-2020 (US$ Mn, AGR %) Figure 272. Cardinal Health, Inc.: Company EBITA 2016-2020 (US$ Mn, AGR %) Figure 273. CR Pharmaceutical.: Company Revenue 2016-2020 (US$ Mn, AGR %) Figure 274. CR Pharmaceutical.: Company Operating Income 2016-2020 (US$ Mn, AGR %) Figure 275. CR Pharmaceutical.: Company Net Income 2016-2020 (US$ Mn, AGR %) Figure 276. CR Pharmaceutical.: Company EBITDA 2016-2020 (US$ Mn, AGR %) Figure 277. McKesson Corporation: Revenue 2017-2021 (US$ Mn, AGR %) Figure 278. McKesson Corporation: Operating Income 2017-2021 (US$ Mn, AGR %) Figure 279. McKesson Corporation: Net Income 2017-2021 (US$ Mn, AGR %) Figure 280. McKesson Corporation: EBITDA 2017-2021 (US$ Mn, AGR %) Figure 281. Medipal Holdings Corporation: Revenue 2017-2021 (US$ Mn, AGR %) Figure 282. Medipal Holdings Corporation: Operating Income 2017-2021 (US$ Mn, AGR %) Figure 283. Medipal Holdings Corporation: Net Income 2017-2021 (US$ Mn, AGR %) Figure 284. Medipal Holding Corporation: EBITDA 2017-2021 (US$ Mn, AGR %)
List of Companies Profiled in the report Alfresa Holdings AmerisourceBergen Corporation Cardinal Health, Inc. China Resources Pharmaceutical Group Limited CR Pharmaceutical CuraScript SD Fortissa Mawdsley-Brooks McKesson Corporation Medipal Holdings Corporation Morris and Dickson Mutual Drug Company PHOENIX Group Prodigy Health Shanghai Fosun Pharmaceutical (Group) Co., Ltd Sinopharm Group Co. Ltd Smith Drug Company Suzuken Co Ltd Walgreens Boots Alliance, Inc.
List of Other Companies Mentioned in the report AAH Pharmaceuticals Ltd. ACCELL CLINICAL RESEARCH LLC APTIV SOLUTIONS Capital Wholesale Drug Company CHILTERN INTERNATIONAL LIMITED Clinipace CONGENIX COVANCE INC. Drogueria Betances, Inc. ECRON ACUNOVA LTD Eli Lilly and Company EzriRx F. Hoffmann-La Roche Ltd FCL Health Solutions Firstline Pharma Ltd. Fortissa Goodwill Pharma H. D. Smith Henry Schein Inc. HyGen Pharmaceuticals, Inc ICON PLC IQVIA Karo Pharma Kingworld Medicines Group Ltd Kolmar Laboratory Corporation of America Letco Medical Masters Pharmaceutical MEDIPAL HOLDINGS Medline Industries Mockingbird Pharma Morris & Dickson North Carolina Mutual Wholesale Drug Novo Nordisk AS Ohki Healthcare Holdings Co., Ltd OTC Direct Owens & Minor, Inc. PAREXEL International Corporation Pfizer Inc. Pharmaceutical Product Development LLC Premium Rx National, LLC Profarma Distribuidora de Produ QK Healthcare Inc. R&S Northeast LLC Realcan Pharmaceutical Group Co RxOneShop Safe Chain Solutions Sanofi Sigma PLC Sun Pharmaceutical Industries Ltd TopRx Value Drug Company Zhejiang Int'l Group Co. Ltd
List of Associations Mentioned in the Report Agência Nacional de Vigilância Sanitária (ANVISA) Central Drugs Standard Control Organization (CDSCO) China FDA (CFDA) Chinese Ministry of Health Comissão Nacional de Ética em Pesquisa (CONEP) Consorcio de Apoyo a la Investigación Biomédica – Plataforma Española de Ensayos Clínicos (CAIBER) Drug Controller General of India (DCGI) European Commission European Medicines Agency (EMA) Food and Drug Administration (FDA) Health Science Authority International Air Transport Association (IATA) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) International Pharmaceutical Federation Japanese Ministry of Health, Labour and Welfare (MHLW) Les Enterprises du Medicament (LEEM) Medicines and Healthcare Products Regulatory Agency (MHRA) National Institutes of Health (NIH) Pharmaceuticals for Human Use (ICH) Transportation Administration Security (TAS) US Pharmacopeia (USP) World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Report 2021-2031
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their...
Increased illness incidence, frequent pandemic outbreaks like as corona and Ebola, and increased expenditures in healthcare facilities such as hospitals...
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead....
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry....
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
